Versican Plus Pi/L4

RSS

Authorised

This medicine is authorised for use in the European Union

canine parainfluenza virus and Leptospira
MedicineVeterinaryAuthorised

Icelandic is available via eTranslation, the European Commission's machine translation service.

Translate to Icelandic | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website.

български (BG) (93.36 KB - PDF)

Skoða

español (ES) (81.97 KB - PDF)

Skoða

čeština (CS) (93.99 KB - PDF)

Skoða

dansk (DA) (83.34 KB - PDF)

Skoða

Deutsch (DE) (82.76 KB - PDF)

Skoða

eesti (ET) (82.18 KB - PDF)

Skoða

ελληνικά (EL) (93.76 KB - PDF)

Skoða

français (FR) (82.44 KB - PDF)

Skoða

Gaeilge (GA) (83.57 KB - PDF)

Skoða

hrvatski (HR) (92.27 KB - PDF)

Skoða

italiano (IT) (82.29 KB - PDF)

Skoða

latviešu (LV) (94.29 KB - PDF)

Skoða

lietuvių (LT) (94.03 KB - PDF)

Skoða

magyar (HU) (94.15 KB - PDF)

Skoða

Malti (MT) (95.95 KB - PDF)

Skoða

Nederlands (NL) (82.05 KB - PDF)

Skoða

polski (PL) (95.62 KB - PDF)

Skoða

português (PT) (83.01 KB - PDF)

Skoða

română (RO) (94.17 KB - PDF)

Skoða

slovenčina (SK) (94.08 KB - PDF)

Skoða

slovenščina (SL) (82.27 KB - PDF)

Skoða

suomi (FI) (81.54 KB - PDF)

Skoða

svenska (SV) (82.05 KB - PDF)

Skoða

Íslenska (IS) (83.29 KB - PDF)

Skoða

norsk (NO) (82 KB - PDF)

Skoða

Product information

български (BG) (91.78 KB - PDF)

Skoða

español (ES) (81.51 KB - PDF)

Skoða

čeština (CS) (92.48 KB - PDF)

Skoða

dansk (DA) (82.05 KB - PDF)

Skoða

Deutsch (DE) (81.72 KB - PDF)

Skoða

eesti (ET) (81.22 KB - PDF)

Skoða

ελληνικά (EL) (91.79 KB - PDF)

Skoða

français (FR) (81.63 KB - PDF)

Skoða

Gaeilge (GA) (81.36 KB - PDF)

Skoða

hrvatski (HR) (91.56 KB - PDF)

Skoða

italiano (IT) (81.76 KB - PDF)

Skoða

latviešu (LV) (92.14 KB - PDF)

Skoða

lietuvių (LT) (92.19 KB - PDF)

Skoða

magyar (HU) (92.76 KB - PDF)

Skoða

Malti (MT) (93.86 KB - PDF)

Skoða

Nederlands (NL) (81.15 KB - PDF)

Skoða

polski (PL) (93.22 KB - PDF)

Skoða

português (PT) (82.53 KB - PDF)

Skoða

română (RO) (91.73 KB - PDF)

Skoða

slovenčina (SK) (81.75 KB - PDF)

Skoða

slovenščina (SL) (81.76 KB - PDF)

Skoða

suomi (FI) (81.11 KB - PDF)

Skoða

svenska (SV) (81.47 KB - PDF)

Skoða

Íslenska (IS) (81.52 KB - PDF)

Skoða

norsk (NO) (81.52 KB - PDF)

Skoða
Latest procedure affecting product information:IB/0012

български (BG) (93.36 KB - PDF)

Skoða

español (ES) (81.97 KB - PDF)

Skoða

čeština (CS) (93.99 KB - PDF)

Skoða

dansk (DA) (83.34 KB - PDF)

Skoða

Deutsch (DE) (82.76 KB - PDF)

Skoða

eesti (ET) (82.18 KB - PDF)

Skoða

ελληνικά (EL) (93.76 KB - PDF)

Skoða

français (FR) (82.44 KB - PDF)

Skoða

Gaeilge (GA) (83.57 KB - PDF)

Skoða

hrvatski (HR) (92.27 KB - PDF)

Skoða

italiano (IT) (82.29 KB - PDF)

Skoða

latviešu (LV) (94.29 KB - PDF)

Skoða

lietuvių (LT) (94.03 KB - PDF)

Skoða

magyar (HU) (94.15 KB - PDF)

Skoða

Malti (MT) (95.95 KB - PDF)

Skoða

Nederlands (NL) (82.05 KB - PDF)

Skoða

polski (PL) (95.62 KB - PDF)

Skoða

português (PT) (83.01 KB - PDF)

Skoða

română (RO) (94.17 KB - PDF)

Skoða

slovenčina (SK) (94.08 KB - PDF)

Skoða

slovenščina (SL) (82.27 KB - PDF)

Skoða

suomi (FI) (81.54 KB - PDF)

Skoða

svenska (SV) (82.05 KB - PDF)

Skoða

Íslenska (IS) (83.29 KB - PDF)

Skoða

norsk (NO) (82 KB - PDF)

Skoða

Product details

Name of medicine
Versican Plus Pi/L4
Active substance
Canine parainfluenza type 2 virus, strain CPiV-2 Bio 15 (live attenuated), Leptospira interrogans serogroup Australis serovar Bratislava, strain MSLB 1088, L. interrogans serogroup Icterohaemorrhagiae serovar Icterohaemorrhagiae, strain MSLB 1089, L. interrogans serogroup Canicola serovar Canicola, strain MSLB 1090 and L. kirschneri serogroup Grippotyphosa serovar Grippotyphosa, strain MSLB 1091 (all inactivated)
International non-proprietary name (INN) or common name
canine parainfluenza virus and Leptospira

Authorisation details

EMA product number
EMEA/V/C/003683

Assessment history

This page was last updated on

Share this page